Delivery Order SPE2DB22D3401-SPE2DB25FT6BM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Vimpat 200 mg tablets in quantities of 60 units, with a firm fixed price ceiling value of $3,455.90. This delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by August 21, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Vimpat is a prescription antiepileptic medication used in the...
- The Defense Logistics Agency Troop Support Medical awarded a $366 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg Vimpat tablets. As the prime contractor, Amerisourcebergen will deliver 60 tablets to a facility in Conshohocken, Pennsylvania under a one day period of performance from September 13th to 14th, 2023. The Defense Logistics Agency utilizes strategic sourcing vehicles to provide medical supplies and pharmaceuticals in support of military treatment...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $721 to Amerisourcebergen Drug Corporation for Vimpat 100mg tablets. The order is for 60 tablets to be delivered to a facility in Conshohocken, Pennsylvania between August 14-15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for anti-seizure medication will support its mission to provide medical supplies and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,763.24 firm-fixed-price delivery order is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- This federal contract award, valued at $1,229.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets, a medication used to treat certain types of epilepsy. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific business category....
- The Defense Logistics Agency awarded a $471,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Vimpat 100mg tablets. Under this order, Amerisourcebergen will deliver 60 tablets of the anti-seizure medication to a location in Conshohocken, Pennsylvania by July 7, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Pharmaceutical Prime Vendor contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.28 firm fixed-price contract is for the delivery of Vimpat 200 mg tablets. It has an ultimate completion date of September 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency Troop Support Medical awarded a $454,000 delivery order to Amerisourcebergen Drug Corporation for Vimpat 50 mg tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60,000 Vimpat tablets to a facility in Conshohocken, Pennsylvania between September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this requirement to support the Defense Logistics Agency's mission of providing...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,248 to Amerisourcebergen Drug Corporation for 50 mg Vimpat tablets. The delivery order was issued against an existing prime vendor contract vehicle and calls for the delivery of 60 Vimpat tablets to a facility located in Conshohocken, Pennsylvania. Performance is required between August 31, 2023 and September 1, 2023. As the Defense Logistics Agency manages the medical supply...
- The Defense Logistics Agency awarded a $1,277.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 Vimpat 100 mg tablets. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from July 7-10, 2023. The purpose of this delivery order is to provide a branded anti-seizure medication to support the healthcare...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6BMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vimpat (levetiracetam) 150 mg tablets in a quantity of 60 units, valued at $1,393.96. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, awarded on September 9, 2025. The contract carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a wide range of pharmaceutical products and medical supplies to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. Through this delivery order, the company continues to support the Defense Health Agency and broader Department of Defense healthcare operations by delivering critical pharmaceutical commodities necessary for military medical readiness and patient care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/9/25 |